Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: A prospective study of 12,008 men in Taiwan

American Journal of Epidemiology

Volumn 157, Issue 8, 2003, Pages 674-682

  Sun, Chien An ^a   Wu, Der Min ^a   Lin, Chia Chin ^a   Lu, Sheng Nan ^b   You, San Lin ^c   Wang, Li Yu ^d   Wu, Mel Hsuan ^a   Chen, Chien Jen ^c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

Author keywords

Confounding factors (epidemiology); Hepatitis; Hepatitis B virus; Hepatitis C like viruses; Liver neoplasms; Risk factors

Indexed keywords

ALANINE AMINOTRANSFERASE; ALCOHOL; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

HEPATITIS;

ADULT; ALCOHOL CONSUMPTION; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; BETEL NUT; CANCER INCIDENCE; CHRONIC HEPATITIS; CIGARETTE SMOKING; COMMUNITY CARE; CONTROLLED STUDY; ENDEMIC DISEASE; ENZYME BLOOD LEVEL; EVALUATION; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; LIFESTYLE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TAIWAN; VIRUS INFECTION;

ADULT; ALANINE TRANSAMINASE; CARCINOMA, HEPATOCELLULAR; CONFOUNDING FACTORS (EPIDEMIOLOGY); FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HEPATITIS B; HEPATITIS C; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 0037446291     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg041     Document Type: Article

References (50)

1. Muir CS, Nectoux J. International patterns of cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. 2nd ed. New York, NY: Oxford University Press, 1996:141-67.
2. Yu MC, Tong MJ, Coursaget P, et al. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst 1990; 82:1038-41.
3. Tanaka K, Hirohata T, Koga S, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842-7.
4. Hadziyannis S, Tabor E, Kaklamani E, et al. A case-control study of hepatitis B and C virus infections in the etiology of hepatocellular carcinoma. Int J Cancer 1995;60:627-31.
5. Yu MW, You SL, Chang AS, et al. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51:5621-5.
6. Kew MC, Houghton M, Choo QL, et al. Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 1990;335:873-4.
7. Okuda K, Fujimoto I, Hanai A, et al. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987;47:4967-72.
8. Bellentani S, Tiribelli C, Saccoccio G, et al. Prevalence of chronic liver disease in the general population of northern Italy: The Dionysos Study. Hepatology 1994;20:1442-9.
9. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745-50.
10. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000; 160:3227-30.
11. Chen CJ, Liang KY, Chang AS, et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma. Hepatology 1991;13:398-406.
12. Yu MC, Tong MJ, Govindarajan S, et al. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the nonAsians of Los Angeles County, California. J Natl Cancer Inst 1991;83:1820-6.
13. Tsai JF, Chuang LY, Jeng JE, et al. Betel quid chewing as a risk factor for hepatocellular carcinoma: a case-control study. Br J Cancer 2001;84:709-13.
14. Chen DS, Kuo GC, Sung JL, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990;162:817-22.
15. Chen CJ, Lu SN, You SL, et al. Community-based hepatocellular carcinoma screening in seven townships in Taiwan. (In Chinese). J Formos Med Assoc 1995;94(suppl 2):S94-102.
16. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997;12:S294-308.
17. Chen KT, Chen CJ, Fagot-Campagna A, et al. Tobacco, betel quid, alcohol, and illicit drug use among 13- to 35-year-olds in I-Lan, rural Taiwan: prevalence and risk factors. Am J Public Health 2001;91:1130-4.
18. Sheu JC, Sung JL, Chen DS, et al. Early detection of hepatocellular carcinoma by real-time ultrasonography: a prospective study. Cancer 1985;56:660-6.
19. Liaw YF. Current therapeutic trends in therapy for chronic viral hepatitis. J Gastroenterol Hepatol 1997;12:S346-53.
20. Yu MW, Hsu FC, Sheen IS, et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol 1997;145:1039-47.
21. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002;347:168-74.
22. Yu MW, Yang YC, Yang SY, et al. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J Natl Cancer Inst 2001;93:1644-51.
23. Aalen O. Nonparametric inference for a family of counting processes. Ann Stat 1978;6:701-26.
24. Pena E, Rohatgi VK. Small sample and efficiency results for the Nelson-Aalen estimator. J Stat Plann Inference 1993;37:192-202.
25. Rothman KJ. Modern epidemiology. Boston, MA: Little, Brown and Company, 1986:322-6.
26. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-6.
27. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, CA: Wadsworth, Inc, 1982:403-18.
28. Chuang WL, Chang WY, Lu SN, et al. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area: a case-control study. Cancer 1992;69:2052-4.
29. Sun CA, Farzadegan H, You SL, et al. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan. Cancer Epidemiol Biomarkers Prev 1996;5:173-8.
30. Nalpas B, Driss F, Pol S, et al. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 1991;12:70-4.
31. Hadziyannis SJ, Giannoulis G, Hadziyannis E, et al. Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma. J Hepatol 1993;17(suppl 3):S72-7.
32. Kaklamani E, Trichopoulos D, Tzonou A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991;265:1974-6.
33. Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol 1994;17:71-91.
34. De Mitri MS, Poussin K, Buccarini P, et al. HCV-associated liver cancer without cirrhosis. Lancet 1995;345:413-15.
35. Oshima A, Tsukuma H, Hiyama T, et al. Follow-up study of HBsAg-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer 1984;34:775-9.
36. Hirayama T. A large-scale cohort study on risk factors for primary liver cancer, with special reference to the role of cigarette smoking. Cancer Chemother Pharmacol 1989;23(suppl):S114-17.
37. Mori M, Hara M, Wada I, et al. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000;151:131-9.
38. Haber MM, West AB, Haber AD, et al. Relationship of aminotransferases to liver histological status in chronic hepatitis C. Am J Gastroenterol 1995;90:1250-7.
39. Shakai AO, Conry-Cantilena C, Alter HJ, et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. Ann Intern Med 1995;123:330-7.
40. Yoshida H, Shiratori Y, Moriyama M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic hepatitis C in Japan. Ann Intern Med 1999;131:174-81.
41. Kato N, Yokosuka O, Hosoda K, et al. Quantitation of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of virus in advanced liver disease. Hepatology 1993;18:16-20.
42. Gretch D, Corey L, Wilson J, et al. Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease. J Infect Dis 1994;169:1219-25.
43. Pozzato G, Kaneko S, Moretti M, et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994;43:291-6.
44. Nousbaum JB, Pol S, Nalpas B, et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995;122:161-8.
45. Silini E, Bottelli R, Asti M, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology 1996;111:199-205.
46. Hagiwara H, Hayashi N, Mita E, et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology 1993;17:545-50.
47. Lau JY, Davis GL, Kniffen J, et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341:1501-4.
48. Benvegnu L, Pontissio P, Cavalletto D, et al. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997;25:211-15.
49. Chen CH, Sheu JC, Wang JT, et al. Genotypes of hepatitis C virus in chronic liver disease in Taiwan. J Med Virol 1994;44:234-6.
50. Kao JH, Lai MY, Chen PJ, et al. Serum hepatitis C virus titers in the progression of type C chronic liver disease: with special emphasis on patients with type 1b infection. J Clin Gastroenterol 1996;23:280-3.